These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38416270)

  • 21. Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer.
    Generalova O; Roy M; Hall E; Shah SA; Cunanan K; Fardeen T; Velazquez B; Chu G; Bruzzone B; Cabot A; Fisher GA; Srinivas S; Fan AC; Haraldsdottir S; Wakelee HA; Neal JW; Padda SK; Johnson T; Heestand GM; Hsieh RW; Ramchandran K
    J Patient Rep Outcomes; 2021 Sep; 5(1):91. PubMed ID: 34524558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study.
    Iivanainen S; Ravichandra R; Jekunen A; Arokoski R; Mentu S; Lang L; Ekström J; Virtanen H; Kataja V; Koivunen JP
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6875-6882. PubMed ID: 36809503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.
    Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM
    BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom.
    Lester J; Escriu C; Khan S; Hudson E; Mansy T; Conn A; Chan S; Powell C; Brock J; Conibear J; Nelless L; Nayar V; Zhuo X; Durand A; Amin A; Martin P; Zhang X; Pawar V
    BMC Cancer; 2021 May; 21(1):515. PubMed ID: 33962574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.
    Wiegel J; Seppen BF; Nurmohamed MT; Ter Wee MM; Bos WH
    Rheumatol Int; 2023 Apr; 43(4):651-657. PubMed ID: 36715728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to implement routine electronic patient-reported outcome monitoring in oncology rehabilitation.
    Wintner LM; Sztankay M; Riedl D; Rumpold G; Nickels A; Licht T; Holzner B
    Int J Clin Pract; 2021 Apr; 75(4):e13694. PubMed ID: 32885565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
    Gan CL; Stukalin I; Meyers DE; Dudani S; Grosjean HAI; Dolter S; Ewanchuk BW; Goutam S; Sander M; Wells C; Pabani A; Cheng T; Monzon J; Morris D; Basappa NS; Pal SK; Wood LA; Donskov F; Choueiri TK; Heng DYC
    Eur J Cancer; 2021 Jul; 151():115-125. PubMed ID: 33975059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
    Navani V; Ernst M; Wells JC; Yuasa T; Takemura K; Donskov F; Basappa NS; Schmidt A; Pal SK; Meza L; Wood LA; Ernst DS; Szabados B; Powles T; McKay RR; Weickhardt A; Suarez C; Kapoor A; Lee JL; Choueiri TK; Heng DYC
    JAMA Netw Open; 2022 Jun; 5(6):e2216379. PubMed ID: 35687336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients.
    Samuel CA; Smith AB; Elkins W; Richmond J; Mahbooba Z; Basch E; Bennett AV; Chung AE; Jonsson M; Chen RC; Reeve BB
    Qual Life Res; 2021 Nov; 30(11):3213-3227. PubMed ID: 32112276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers.
    Ayers KL; Mullaney T; Zhou X; Liu JJ; Lee K; Ma M; Jones S; Li L; Redfern A; Jappe W; Liu Z; Goldsweig H; Yadav KK; Hahner N; Dietz M; Zimmerman M; Prentice T; Newman S; Veluswamy R; Wisnivesky J; Hirsch FR; Oh WK; Li SD; Schadt EE; Chen R
    Oncologist; 2021 Jul; 26(7):e1226-e1239. PubMed ID: 33829580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of Large-Scale Implementation of an Electronic Patient-Reported Outcome Remote Monitoring System for Patients on Active Treatment at a Community Cancer Center.
    Cherny NI; Parrinello CM; Kwiatkowsky L; Hunnicutt J; Beck T; Schaefer E; Thurow T; Kolodziej M
    JCO Oncol Pract; 2022 Dec; 18(12):e1918-e1926. PubMed ID: 36240475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the Implementation and Effectiveness of the Electronic Patient-Reported Outcome Tool for Older Adults With Complex Care Needs: Mixed Methods Study.
    Steele Gray C; Chau E; Tahsin F; Harvey S; Loganathan M; McKinstry B; Mercer SW; Nie JX; Palen TE; Ramsay T; Thavorn K; Upshur R; Wodchis WP
    J Med Internet Res; 2021 Dec; 23(12):e29071. PubMed ID: 34860675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.
    Trojan A; Roth S; Atassi Z; Kiessling M; Zenhaeusern R; Kadvany Y; Schumacher J; Kullak-Ublick GA; Aapro M; Eniu A
    JMIR Cancer; 2024 Apr; 10():e54178. PubMed ID: 38573759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
    Meagher MF; Minervini A; Mir MC; Cerrato C; Rebez G; Autorino R; Hampton L; Campi R; Kriegmair M; Linares E; Hevia V; Musquera M; D'Anna M; Roussel E; Albersen M; Pavan N; Claps F; Antonelli A; Marchioni M; Paksoy N; Erdem S; Derweesh IH
    Eur Urol Open Sci; 2024 May; 63():71-80. PubMed ID: 38572300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data Quality of Longitudinally Collected Patient-Reported Outcomes After Thoracic Surgery: Comparison of Paper- and Web-Based Assessments.
    Yu H; Yu Q; Nie Y; Xu W; Pu Y; Dai W; Wei X; Shi Q
    J Med Internet Res; 2021 Nov; 23(11):e28915. PubMed ID: 34751657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.
    Trojan A; Leuthold N; Thomssen C; Rody A; Winder T; Jakob A; Egger C; Held U; Jackisch C
    J Med Internet Res; 2021 Aug; 23(8):e29271. PubMed ID: 34383675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma.
    Esterberg E; Iyer S; Nagar SP; Davis KL; Tannir NM
    Clin Genitourin Cancer; 2024 Apr; 22(2):115-125.e3. PubMed ID: 37914609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
    Danesi V; Massa I; Foca F; Delmonte A; Crinò L; Bronte G; Ragonesi M; Maltoni R; Manunta S; Cravero P; Andrikou K; Priano I; Balzi W; Gentili N; Burke T; Altini M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era.
    Shah NJ; Sura SD; Shinde R; Shi J; Singhal PK; Robert NJ; Vogelzang NJ; Perini RF; Motzer RJ
    Eur Urol Open Sci; 2023 Mar; 49():110-118. PubMed ID: 36874600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets.
    McKelvey BA; Berk A; Chin L; Hudgens S; Kudel I; O'Hagan RC; Patel A; Scott J; Stires H; Wang S; Wujcik D; Stewart M; Allen J
    JCO Clin Cancer Inform; 2023 Feb; 7():e2200161. PubMed ID: 36821804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.